Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA608035
Max Phase: Preclinical
Molecular Formula: C27H35N8O17P
Molecular Weight: 774.59
Molecule Type: Small molecule
Associated Items:
ID: ALA608035
Max Phase: Preclinical
Molecular Formula: C27H35N8O17P
Molecular Weight: 774.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC1C(O)CC(OP(=O)(O)OC[C@H]2OC(n3ccc(N)nc3=O)[C@H](O)[C@@H]2O)(C(=O)O)OC1[C@H](O)[C@H](O)CNC(=O)c1ccc(N=[N+]=[N-])cc1O
Standard InChI: InChI=1S/C27H35N8O17P/c1-10(36)31-18-14(38)7-27(25(44)45,51-22(18)19(40)15(39)8-30-23(43)12-3-2-11(33-34-29)6-13(12)37)52-53(47,48)49-9-16-20(41)21(42)24(50-16)35-5-4-17(28)32-26(35)46/h2-6,14-16,18-22,24,37-42H,7-9H2,1H3,(H,30,43)(H,31,36)(H,44,45)(H,47,48)(H2,28,32,46)/t14?,15-,16-,18?,19-,20-,21-,22?,24?,27?/m1/s1
Standard InChI Key: BZCRWZPANOPTGW-IIEMJKPCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 774.59 | Molecular Weight (Monoisotopic): 774.1858 | AlogP: -3.19 | #Rotatable Bonds: 14 |
Polar Surface Area: 400.77 | Molecular Species: ACID | HBA: 19 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 25 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.65 | CX Basic pKa: | CX LogP: -3.26 | CX LogD: -9.43 |
Aromatic Rings: 2 | Heavy Atoms: 53 | QED Weighted: 0.04 | Np Likeness Score: 0.86 |
1. Mirelis P, Brossmer R. (1995) Photoreactive CMP-sialic acids as substrates for 2,6-sialyltransferase, 5 (23): [10.1016/0960-894X(95)00491-B] |
Source(1):